1887

Chapter 7.6 : N A A P I S

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

N A A P I S, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818814/9781555818814_Chap7.6-1.gif /docserver/preview/fulltext/10.1128/9781555818814/9781555818814_Chap7.6-2.gif

Abstract:

The Xpert MTB/RIF assay, which is performed on the GeneXpert platform, employs an individual plastic cartridge into which a respiratory sample, pretreated with a provided reagent that liquefies the sputum and decreases the viability of mycobacteria (and other bacteria), is added. The cartridge is placed in the GeneXpert instrument, which integrates and automates sputum sample processing, two rounds of nucleic acid amplification, and detection of the target sequences using real-time PCR ( ). The system consists of an instrument, computer, barcode scanner, and preloaded software that controls the process within the cartridge. The system requires single-use disposable GeneXpert cartridges that hold the PCR reagents and host the PCR process. Because the cartridges are self-contained, cross-contamination between samples is unlikely. The Xpert MTB/RIF Assay includes reagents for the detection of (MTB) complex and rifampin (RIF) resistance and a sample processing control (SPC) to ensure adequate processing of the target bacteria and to monitor for the presence of inhibitors in the PCR reaction. The Probe Check Control (PCC) verifies that the reagent has dissolved in the diluent, that the PCR tube has filled with the liquid reagent in the cartridge, that the probe is working, and that the dye is stable.

Citation: Leber A. 2016. N A A P I S, p 7.6.1.1-7.6.2.7. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch7.6
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818814.chap7.6
1. Piatek AS, Telenti A, Murray MR, El-Hajj H, Jacobs WRJr., Kramer FR, Alland D. 2000. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother 44:103110.
2. Piatek AS, Tyagi S, Pol AC, Telenti A, Miller LP, Kramer FR, Alland D. 1998. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol 16:359363.
3. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-Lopez EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D. 2009. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48:229237.
4. El-Hajj HH, Marras SA, Tyagi S, Kramer FR, Alland D. 2001. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol 39:41314137.
5. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O’Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363:10051015.
6. Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W. 2011. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med 8:e1001061.
7. Williamson DA, Roberts SA, Bower JE, Vaughan R, Newton S, Lowe O, Lewis CA, Freeman JT. 2012. Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 16:216220.
1. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (ed). 2007. Manual of Clinical Microbiology, 9th ed. ASM Press, Washington, DC (ISBN-10:1-55581-371-2 [set]).
2. Van Soolingen D, Hoogenboezem T, de Haas PE, Hermans PW, Koedam MA, Teppema KS, Brennan PJ, Besra GS, Portaels F, Top J, Schouls LM, van Embden JD. 1997. A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Intl J Syst Bacteriol 47:12361245.
3. Gen-Probe. 1995–2013. Gen-Probe Amplified Mycobacterium tuberculosis Direct Test Instructions for Use. Gen-Probe Incorporated, San Diego, CA.
4. CDC. 2009. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 58:710.
5. Kent PT, Kubica GP. 1985. Public Health Mycobacteriology: A Guide for the Level III Laboratory. US Department of Public Health and Human Services, Atlanta, GA.
6. Della-Latta P, Jonas V. 1999. Inhibitory effect of Alpha-Tec XPR-Plus phosphate buffer on the enhanced Gen-Probe Amplified Mycobacterium tuberculosis Direct Test. J Clin Microbiol 37:12341235.
14. Chedore P, Jamieson FB. 1999. Routine use of the Gen-Probe MTD2 amplification test for detection of Mycobacterium tuberculosis in clinical specimens in a large public health mycobacteriology laboratory. Diagn Microbiol Infect Dis 35:185191.
15. Chedore P, Jamieson FB. 2002. Rapid molecular diagnosis of tuberculous meningitis using the Gen-Probe Amplified Mycobacterium tuberculosis Direct Test in a large Canadian public health laboratory. Int J Tuberc Lung Dis. 6:913919.
16. Cloud JL, Shutt C, Aldous W, Woods G. 2004. Evaluation of a modified Gen-Probe Amplified Direct Test for detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid. J Clin Microbiol 42:53415344.
17. Woods GL, Bergman JS, Williams-Bouyer N. 2001 Clinical evaluation of the Gen-Probe amplified Mycobacterium tuberculosis direct test for rapid detection of Mycobacterium tuberculosis in select nonrespiratory specimens. J Clin Microbiol 39:747749.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error